Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02178553 · ClinicalTrials.gov registry record · Phase 4

Study of Exparel Versus Epidural for Pain Control After Thoracotomy

A Phase 4 study, sponsored by Mayo Clinic.

Completed
Registry status
Phase 4
Development phase
102
Enrollment target

NCT02178553: Completed Phase 4 study, sponsored by Mayo Clinic.

NCT02178553 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 102 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02178553, a Phase 4 study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 4
Development phase
102 participants
Enrollment target

Study Summary

Unilateral intercostal nerve blocks provide pain control as effectively as a continuous thoracic epidural, and will a lower incidence of side effects.

Primary Outcome

Pain with cough documented using the numerical rating scale pain scores (0-10)

Interventions

  • DRUG Epidural
  • DRUG Intercostal Bupivicaine (Exparel)

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2014-10-15
Est. Completion 2019-01-25
Phase Phase 4
Mayo Clinic

2,844 total trials

What the finished NCT02178553 record still lists

NCT02178553 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (80% lower).

The record links to 0 conditions, and to 2 interventions - of which Epidural is the first listed.

NCT02178553 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02178553 about?

NCT02178553 is a clinical study titled "Study of Exparel Versus Epidural for Pain Control After Thoracotomy". Unilateral intercostal nerve blocks provide pain control as effectively as a continuous thoracic epidural, and will a lower incidence of side effects.

What is the current status of trial NCT02178553?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2014-10-15. Estimated completion is 2019-01-25.

What interventions are being tested in trial NCT02178553?

The interventions under investigation include: Epidural (DRUG), Intercostal Bupivicaine (Exparel) (DRUG).

Who is sponsoring clinical trial NCT02178553?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02178553's enrollment target sits among peer trials

102 764th of 2000 higher than 1,235 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02178553, the US trial registry maintained by the National Library of Medicine. NCT02178553 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.